Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
STATE COMPANY FOR MARKETING DRUGS MEDICAL APPLIANCES has floated a tender for Supply of Pertuzumab 420 mg IV vial, Ocrelizumab 300 mg/10ml vial. The project location is Iraq and the tender is closing on 25 Mar 2024. The tender notice number is MED/5/2024 Aa, while the TOT Ref Number is 98591160. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Iraq
Summary : Supply of Pertuzumab 420 mg IV vial, Ocrelizumab 300 mg/10ml vial
Deadline : 25 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 98591160
Document Ref. No. : MED/5/2024 Aa
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tenders are invited for Supply of Pertuzumab 420 mg IV vial, Ocrelizumab 300 mg/10ml vial.
Purchase of Drugs and Vaccines
Payment of a non-refundable fee with lump sum as follows:
a- (1.000.000)one million Iraqi Dinar of the tender that less than (1.000.000) Dollars .
b- (2.000.000)two million Iraqi Dinar for the tender that more than (1.000.000) Dinar.
A Bid Security at ratio 1%
Documents
Want To Bid in This Tender?
Get Local Agent Support in Iraq and 60 More Countries.
View Tenders By
Sign in with Google